Press ENTER to search
26 Nov 2024

CAMBRIDGE, Mass., Nov. 26, 2024 – Invaio Sciences, a Flagship Pioneering bioplatform company focused on accelerating the leap to nature-positive agriculture, is pleased to announce the appointments of Chris Judd as Chief Commercial Officer (CCO) and Scott Kantor as Chief Financial Officer (CFO). These strategic additions to Invaio’s leadership team mark an exciting phase in the company’s mission to revolutionize crop health and productivity.

Chris Judd, a seasoned marketing and commercial leader in biotechnology and agricultural innovation, brings a wealth of experience to his new role. Chris has held leadership positions at global companies such as BASF, Novozymes, and Certis Biologicals. His achievements include launching new biological solutions, driving international business growth, and spearheading transformative marketing strategies. With a track record of delivering double-digit growth and improving profitability across diverse markets, Chris will oversee Invaio’s commercial operations, ensuring the company continues to expand its global footprint and deliver impactful solutions to growers worldwide.

Scott Kantor joins Invaio as an accomplished financial executive with over two decades of experience in global financial management, M&A, and business transformation. Most recently, Scott served as CFO at Emulate, Inc., where he played a pivotal role in driving financial discipline and sustainable growth. His extensive background in private equity-backed and publicly traded companies spans high-tech, biotech, and life sciences industries. Scott’s leadership has consistently delivered value through strategic planning, organizational transformation, and talent development. A seasond finance professional, Scott is well-positioned to advance Invaio’s financial strategy and operational excellence.

“We are thrilled to welcome Chris and Scott to Invaio Sciences,” said Amy O’Shea, CEO of Invaio Sciences. “Their deep expertise and proven leadership will be instrumental as we continue to accelerate our efforts in providing sustainable and science-driven solutions for agriculture. Scott’s financial acumen and Chris’s commercial vision align perfectly with our goals to scale and innovate.”

Scott and Chris’s appointments underscore Invaio’s commitment to assembling a world-class leadership team to drive the company’s growth and impact in the agricultural sector.

Media Contact:
[email protected]

About Invaio Sciences
Invaio Sciences, a Flagship Pioneering company, is a bioplatform company accelerating the leap to nature-positive agriculture. The company builds on advances in human health and digital innovation to develop biological technologies for crop health, enabling farmers to both improve yields and use more natural crop health solutions. Invaio is addressing consumer demands and unlocking radical benefits for farmers and the environment, leaving every acre better today and for generations to come. For more information, please visit www.invaio.com or follow Invaio on X (Twitter) or LinkedIn.